by Symmetron | Jan 21, 2019
Rheumatoid arthritis  Economic evaluation of tocilizumab combination in the treatment of moderate to severe rheumatoid arthritis in Italy Journal of Medical Economics. 2012;15(3):576-85 Authors Diamantopoulos A, Benucci M, Capri S, Berger W, Wintfeld N, Giuliani G,...
by Symmetron | Jan 21, 2019
Cancer An economic evaluation of cetuximab combined with radiotherapy for patients with locally advanced head and neck cancer in Belgium, France, Italy, Switzerland, and the United Kingdom Value in Health. 2008;11(5):791-9 Authors Brown B, Diamantopoulos A, Bernier J,...
by Symmetron | Jan 17, 2019
Venous Thromboembolism  Cost-effectiveness impact of rivaroxaban versus new and existing prophylaxis for the prevention of venous thromboembolism after total hip or knee replacement surgery in France, Italy and Spain Thrombosis and Haemostasis. 2013 Nov;110(5):987-94...
Recent Comments